Introduction
X-linked lymphoproliferative disease (XLP) is an inherited immunodeficiency with variable phenotypes often associated with EpsteinBarr virus (EBV) infection. The most frequent clinical manifestations of XLP are fatal or severe infectious mononucleosis, hypo-or agammaglobulinemia, and non-Hodgkin lymphoma of Burkitt type. 1, 2 It has been demonstrated that inactivation or dysfunction of SAP (also called SH2D1A or DSHP) is responsible for this disease. [3] [4] [5] The signaling lymphocytic activation molecule (SLAM)-associated protein (SAP), a small cytoplasmic protein that contains a single Src homologyy 2 (SH2) domain, is expressed at high levels in T and natural killer (NK) cells. SAP interacts through its SH2 domain with tyrosine residues located in the cytoplasmic domains of several molecules of the SLAM/CD2 receptor family, including SLAM, 5 2B4, 6 NTB-A, 7 CD84 and Ly9, 8, 9 and CRACC. 10 Earlier studies showed that SAP regulates the signal transduction of the SLAM/CD2 family receptors by interfering with the recruitment of the tyrosine phosphatase SHP-2. 5, 11 Recently, compelling evidence was provided that SAP behaves as a signaling adapter permitting the recruitment of the protein tyrosine kinase FynT [11] [12] [13] [14] and the 5Ј inositol phosphatase SHIP. 12, 15 In patients with XLP, the SAP protein is either absent or structurally altered due to germ line mutations of the SAP gene, and may thus fail to regulate the SLAM/CD2 receptors signaling events. [3] [4] [5] [16] [17] [18] [19] Sap-deficient mice have been generated to study the cellular basis of XLP. In 2 Sap-deficient mouse models, infection with lymphocytic choriomeningitis virus (LCMV) or Toxoplasma gondii led to hyperproliferation of interferon gamma (IFN-␥)-producing T cells and decreased antibody responses. [20] [21] [22] We have reported the generation and characterization of a third Sap-deficient mouse model that displays hyperactivation of the CD8 ϩ cells and decreased level of total serum immunoglobulin E (IgE) and IgG both before and after murine gammaherpesvirus 68 (MHV-68) infection. 23 Moreover, a defect in natural killer T (NKT) cell development has been observed in the above-mentioned mouse models and in humans. [24] [25] [26] Previous investigations revealed an altered in vivo Th2 cytokine profile in Sap-deficient mice, indicating that impaired Th2 differentiation accounts for the uncontrolled expansion of Th1 cells, [20] [21] [22] [23] as well as the impaired Ig production by B cells 20, 21, 27 and the lack of long-lived plasma cells/memory B cells in Sap-deficient mice. 22 Only recently, the widely accepted hypothesis that XLP is exclusively a T and NK defect was challenged by Morra et al, who demonstrated defective B-cell responses in the absence of SAP by an in vivo approach. 28 In parallel, we have addressed the question of whether SAP has a direct role in B cells by an in vitro assay. In the present study, we report the impaired Ig switch recombination in Sap-deficient B cells, indicating an intrinsic B-cell defect.
Materials and methods

Mice
The generation of the Sap-deficient mice in 129/SvϫC57BL/6 mixed background was previously reported. 23 The mutant mice were back-crossed to a C57BL/6 background for more than 10 generations. Mice were bred and housed under specific pathogen-free conditions at the International Agency for Research on Cancer (IARC). Age-matched mutant and wildtype male mice, aged 2 to 6 months, were used.
Flow cytometry
Single-cell suspensions from indicated organs were depleted of erythrocytes by lysis in hemolytic gey solution. Cells (1.0 ϫ 10 6 ) were preincubated with Fc block (rat IgG2b anti-CD16/32, clone 2.4G2; BD/ PharMingen, San Diego, CA) for 5 minutes at 4°C prior to staining with antibodies conjugated to fluorescein isothiocyanate (FITC), phycoerythrin (PE), tricolor (TC), allophycocyanin (APC), or biotin. Biotin conjugates were visualized with fluochrome-conjugated Strepavidin (BD/PharMingen). The following antimouse monoclonal antibodies (mAbs) were purchased from BD/PharMingen, Caltag (Burlingame, CA), or SouthernBiotech (Birmingham, AL): anti-B220 (RA3-6B2), anti-CD43 (S7), anti-BP-1 (6C3), anti-CD24 (M1/69), anti-IgM (R6-60.2), anti-IgD (11-26c.2a), anti-CD5 (53-7.3), anti-CD21/CD35 (7G6), anti-CD23 (B4B4), anti-CD69 (H1.2F3), anti-CD3e (500-A2), anti-CD4 (CT-CD4), anti-CD8a (CTCD8a), anti-NK1.1 (PK136), and anti-2B4. Cells (10 000) were acquired on a FACSCalibur flow cytometer (BD Labware, Franklin Lakes, NJ) and analyzed with WinMDI.
Positive selection of B cells and amplification of the Sap transcript
Splenocytes were stained with anti-CD3-FITC (500-A2) and anti-CD19-Tricolor (6D5; Caltag), and sorted into CD19 ϩ and CD3 ϩ populations using FACSVantage SE (BD Labware). Total RNA was prepared from the sorted cells by RNeasy kit (Qiagen, Hilden, Germany) and was reverse transcribed by GeneAmp RT-PCR Core kit (Applied Biosystems/Roche, Branchburg, NJ). The SAP, 23 ␤-actin, 29 and CD3 30 transcripts were amplified as described previously.
Negative selection of B cells and Western blot hybridization
Splenocytes were stained with PE-conjugated anti-mouse CD3e (500-A2), CD4 (GK1.5), CD8a (53-6.7), NK1.1 (PK136), and 2B4 (BD/PharMingen). The cells positive for these markers were depleted by the MACS anti-PE MicroBeads and MACS separation columns (Milteni Biotec, Bergisch Gladbach, Germany). After the depletion, plastic-adhering cells were removed by incubation at 37°C for 1.5 hours. SAP protein in cell extracts after immunoprecipitation was visualized by immunoblotting using polyclonal rabbit anti-SAP antibodies as described previously. 12 Purification and culture of the small resting B cells B cells were purified in 2 stages. First, they were negatively selected from splenocytes by immunomagnetic depletion with mouse Pan T, CD4, and CD8 beads from Dynal Biotech (Oslo, Norway). Second, small resting B cells were fractionated by centrifugation through a discontinuous Percoll gradient. 31 Cells (0.5 ϫ 10 6 cells/mL) were stimulated in 96-well plates, 24-well plates, or T75 cell culture flasks with 10 g/mL lipopolysaccharide (LPS; Sigma, St Louis, MO) or 1 g/mL anti-mouse CD40 (BD/ PharMingen), in combination with the following cytokines from R&D Systems (Menneapolis, MN): 10 ng/mL interleukin 4 (IL-4), 10 ng/mL IFN-␥, or 0.5 ng/mL transforming growth factor-␤1 (TGF-␤1). To obtain an optimal cell growth, stimulation by TGF-␤1 is carried out in the presence of 8 ng/mL IL-4 and 0.25 ng/mL IL-5, as described by Snapper et al. 32 The cells were cultured in RPMI 1640 medium or Dulbecco modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum, 2 mM glutamine, 0.1 mM nonessential amino acids, 0.1 mM ␤-mercaptolethanol, 1 mM sodium pyruvate, 100 U/mL penicillin, 100 g/mL streptomycin (all from Invitrogen/GIBCO, Groningen, The Netherlands). The proliferative response of B cells under the above conditions was measured by assessing [ 3 H] thymidine incorporation.
Measurement of immunoglobulin secretion and circular transcripts
Ig titers from the supernatant of cultured B cells (1.0 ϫ 10 6 cells/24-well at the start of stimulation) were determined by enzyme-linked immunosorbent assay (ELISA) as previously described, 23 except for IgG2a, whose counter part is IgG2c in C57BL/6 mouse background. 33 For measuring IgG2c, goat anti-mouse IgG (HϩL) (Jackson Immunoresearch Laboratories, West Grove, PA) was used as capture antibody, and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG2c (SouthernBiotech) as detecting antibody. Cells (20 ϫ 10 6 ) were harvested at different time points after stimulation. Total RNA was extracted from the stimulated cells by Trizol Reagent (Invitrogen), and was reverse transcribed as described under "Positive selection of B cells and amplification of the Sap transcript." The circular transcripts of I␣ and all subtypes of I␥ were amplified following the protocols reported by Kinoshita et al. 34 The ␤-actin transcript was amplified by polymerase chain reaction (PCR) conditions described previously. 29 
Results
Normal B-cell development in Sap-deficient mice
The striking defect in the 3 Sap-deficient mouse models is the dysregulation in Ig production. [20] [21] [22] [23] We previously showed comparable cell numbers and percentages of CD19 ϩ as well as CD3 ϩ , CD4 ϩ , and CD8 ϩ populations in Sap-deficient and wild-type littermate mice. 23 In order to study whether impaired Ig production is due to a lack of specific B-cell subtypes, in addition to defective CD4 ϩ function, we analyzed the B-cell subsets in the bone marrow, spleen, and peritoneal cavity. As shown in Figure 1 , the proportions of early B cells in the bone marrow (according to Hardy fraction classification 35 (B220/CD43/BP-1/CD24) ( Figure 1A ), mature B cells in the spleen (B220 ϩ IgM ϩ , IgM ϩ IgD ϩ , IgM ϩ CD5 ϩ , IgM ϩ CD21 ϩ , and CD21 ϩ CD23 ϩ cells) ( Figure 1B) , and peritoneal B1 population (B220 ϩ CD5 ϩ ) ( Figure 1C ) were comparable in wild-type and mutant mice, indicating that the major B-cell subtypes develop normally in Sap-deficient mice.
Expression of SAP in B cells
To address whether SAP plays a role in B-cell function, we assessed SAP expression in wild-type B cells. We purified B lymphocytes and performed reverse transcriptase (RT)-PCR and immunoprecipitation/immunoblot to examine Sap mRNA and SAP protein expressions. Using positive selection by fluorescence activated cell sorting (FACS), we obtained a CD19 ϩ population with less than 0.12% of the CD3 ϩ , CD4 ϩ , CD8 ϩ , NK1.1 ϩ , and 2B4 ϩ cells (data not shown). Using negative selection, we obtained B-cell preparations with less than 1% of the T or NK contaminants (data not shown). Semiquantitative RT-PCR analysis of RNA prepared from the sorted CD19 ϩ cells and from the negatively enriched B cells revealed the presence of the Sap mRNA, albeit at a lower level than in thymocytes, splenocytes, or sorted CD3 ϩ cells (Figure 2A) . Interestingly, Sap expression was down-regulated after B-cell stimulation with LPS plus IL-4 ( Figure 2A ). Due to the limited number of cells available from FACS, the SAP protein was studied in negatively selected B cells. Consistent with the aforementioned expression of the Sap mRNA (Figure 2A ), the SAP protein was present at low levels in B-cell extracts, and decreased gradually following LPS plus IL-4 stimulation ( Figure 2B ). To test the purity of the enriched B cells, CD3 ϩ transcript was measured in the RNA samples by RT-PCR. Although no amplification band was found in the positively selected B cells or in the B cells after stimulation, a very faint amplification band was detected in the negatively enriched B-cell preparation (Figure 2A ). Subsequently, we performed a mixing experiment to rule out the possibility that the Sap-transcript or the SAP protein observed in the RT-PCR and Western assays originate from trace T-cell contamination. Purified B cells from Sap-deficient mice that are devoid of SAP were mixed with T cells from wild-type mice to mimic various extents of T-cell contamination and then examined for SAP protein expression. As shown in Figure 2B , 1% and 2% of T-cell contamination generate faint signals in comparison to SAP expression in wild-type B-cell preparations. Only when T-cell contamination reaches 4% does the T-cell-derived SAP signal become comparable with that from the wild-type B cells. Since, as shown by FACS analysis, T cells represent fewer than 1% of the enriched B-cell population used in our experiments, it could be excluded as the source of the positive SAP signal in purified B cells.
Decreased IgG and IgA production in Sap-deficient B cells
Since SAP was shown to be expressed in wild-type B cells, we investigated the impact of SAP deficiency on B-cell function, in particular, Ig production. In order to eliminate any in vivo preprogramming/interference, we used small resting B cells, which represent the mature naive B-cell population. The small resting B cells were isolated from the spleen by negative selection followed by density centrifugation. The resulting cell population was 92% B220 ϩ and contained fewer than 0.8% CD3 ϩ cells (Figure 3) , as assessed by flow cytometry. Of the B220 ϩ cells, 98% were IgM ϩ , and 94% were IgM ϩ IgD ϩ (Figure 3 ). The percentages of the B220 ϩ CD43 ϩ and B220 ϩ CD69 ϩ populations, representing the mature activated B cells, were low in both Sap-deficient and wild-type cell preparations (Figure 3) . In order to study Ig production, these isolated small resting B cells were stimulated for 6 days with LPS in combination with IL-4, IFN-␥, or TGF-␤1, and the secreted immunoglobulins were measured by ELISA. As shown in Figure 4 , the IgM and IgE levels were comparable in both genotypes; however, IgG and IgA production was impaired in Sap-deficient B cells under most conditions. In particular, the levels of secreted IgG2c (equivalent to IgG2a in C57BL/6 background 33 ), IgG2b, IgG3, and IgA were significantly lower in Sap-deficient B cells compared with wild-type B cells (Figure 4) .
In order to rule out the possibility that the decreased in vitro Ig production was due to poor outgrowth of the Sap-deficient B cells during culture, we assessed the proliferation rates of the cultured cells by measuring the incorporated [ 3 H]-thymidine. As shown in Figure 5 , the proliferation rates of Sap-deficient and wild-type B cells were comparable. Moreover, numbers of Sap-deficient and wild-type live B cells, determined by trypan blue exclusion, were similar at various time points (data not shown). For personal use only. on July 13, 2017. by guest www.bloodjournal.org From
Impaired Ig class switch recombination in Sap-deficient B cells
Subsequently, we addressed whether the decreased IgG2c, IgG2b, IgG3, and IgA production is due to a defect of Ig class switch recombination (CSR). Kinoshita et al demonstrated that CSR can be determined by measuring the abundance of RNA transcripts from the looped-out circular DNA. 34 We studied the expression level of I␥2a, I␥2b, I␥3, and I␣ circular transcripts in Sap-deficient and wild-type B cells activated by LPS in combination with IL-4, IFN-␥, or TGF-␤1. All 4 stimulation conditions led to detectable levels of I␥2b and I␥3 transcripts after 36 hours of treatment; however, transcript levels were lower in Sap-deficient B cells than in wild-type B cells ( Figure  6A ). Similarly, I␥2a and I␣ transcripts, which are clearly induced after 3 days of stimulation by IFN-␥ and TGF-␤1, respectively, were found to be significantly lower in Sapdeficient B cells than in wild-type B cells ( Figure 6A ). In addition, we analyzed the response of B cells following a more physiologic stimulation, anti-CD40 in combination with the 3 cytokines. All the aforementioned circular transcripts were measured. I␥2b and I␥3 were undetectable (not shown). However, I␥2a and I␣ transcripts were dramatically lower in anti-CD40 plus IFN-␥-and anti-CD40 plus TGF-␤1-stimulated Sap-deficient B cells as compared with wild-type B cells ( Figure 6B ).
Discussion
To study the role of SAP in the immune system, several laboratories including ours have generated Sap knockout mice. 20 27 showed that only the T-dependent antibody responses are impaired in Sap-deficient mice, and more recently, Ma et al 36 reported the lack of isotype-switched memory B cells in the peripheral blood of the patients with XLP, which is associated with defective IL-10 production by CD4 ϩ T cells. However, whereas the T-cell defect has been unequivocally demonstrated, none of these studies have excluded the possibility of an intrinsic functional defect in a subset of Sap-deficient B cells. To address this question, we examined the B-cell compartment in Sapdeficient mice. Purified small resting B cells were used to study in vitro Ig production following stimulation with LPS and anti-CD40 in combination with IL-4, IFN-␥, and TGF-␤1. We observed impaired IgG and IgA production in Sap-deficient B cells, and we demonstrated that this was not a result of either abnormal growth during the cell culture or altered development of the major B-cell subpopulations. Thus, these data expand the role of SAP in regulating cellular functions to include the B-cell compartment. Consistent with our finding, a recent study provides convincing evidence demonstrating the presence of defective B-cell responses in a Sap-deficient background by adoptive transfer of wild-type and Sap-deficient T and B cells. 28 While some studies reported the absence of the SAP protein in B-cell lysates, 37, 38 others showed that SAP is expressed in B cells of the interfollicular zone of the tonsil and lymph nodes of the humans 39 and in follicular germinal center (GC) B cells in the spleen and lymph nodes in humans 4 or in the mouse. 28 Moreover, it has been shown that the SAP protein is detectable in Hodgkin and non-Hodgkin lymphoma, tonsillar B cells, some B-cell lines, and Burkitt lymphoma cell lines. 4, 15, 38, 39 We observed the expression of the Sap mRNA and the SAP protein in B cells from wild-type mice, although at very low levels ( Figure 2) . We also showed that activation of wild-type, mature naive B cells by LPS in the presence of IL-4 down-regulates the transcript and the protein product of the Sap gene. This result indicates that SAP is a tightly controlled molecule, expressed transiently in a specific stage or stages of B-cell differentiation. The exact subset of B cells expressing SAP and the signaling pathways that are regulated by SAP in B cells remain to be elucidated. One plausible model is that SAP regulates B-cell function by interacting with SLAM, as engagement of SLAM in B cells has been shown to enhance B-cell proliferation and Ig production. 40 This is supported by the results of Mikhalap et al, who showed that SAP and SLAM are coexpressed in B cells in the interfollicular zone. 39 It is also possible that SAP interferes with B-cell function through CD84 signaling, which is up-regulated in memory B cells and recruits SAP. 8, 9 Finally, all the SLAM family members with the exception of 2B4 are expressed on B cells, and therefore are good candidates for further investigation.
It is well established that LPS stimulation of B cells in the presence of cytokines can induce in vitro isotype switching. 41 Results in Figure 4 demonstrate that Sap-deficient B cells produce lower levels of IgG2c, IgG2b, IgG3, and IgA in vitro than do wild-type B cells. This defect is not caused by abnormal proliferation of Sap-deficient B cells in response to the stimulation ( Figure  5) ; instead, it reflects an impaired function of B cells. To exclude the possibility that the reduction in Ig production of Sap-deficient B cells was a result of a decrease in the number of memory B cells, we used small resting B cells, which were principally B220 ϩ IgM ϩ (98%). The proportion of B220 ϩ IgM Ϫ cells, which might represent the switched IgG ϩ or IgA ϩ cells, was very low and comparable in Sap-deficient and in wild-type B-cell preparations. We also excluded the possibility that decreased Ig production in Sap-deficient B cells is due to a lower percentage of activated B cells before stimulation, since percentages of the B220 ϩ CD43 ϩ and B220 ϩ CD69 ϩ populations are equally low in Sap-deficient and in wild-type B cells (Figure 3) . It is worth noting that the impairment of Ig production in Sap-deficient B cells is only partial. Consistent with our observations, Morra et al observed that whereas the follicular GC B cells are affected in Sap-deficient mice, mature B cells outside the GC and T-independent responses are normal. 28 Therefore, one could speculate that the absence of SAP leads to a defect in Ig class switch only in the subset of B cells expressing SAP and that this defect is partially masked by the presence of functionally unaltered B cells in the total B-cell compartment. For personal use only. on July 13, 2017. by guest www.bloodjournal.org From
To study the mechanism of the impaired Ig secretion, we measured the CSR rates in Sap-deficient and wild-type B cells to study the isotype switching process. After cytokine stimulation, CSR is accompanied by looping-out DNA segments between the C switch region and one of the downstream switch regions of each C H gene, including its I promoter. 34 Kinoshita et al have shown that the I promoter is active in the excised circular DNAs and directs the production of circular transcripts, which are sensitive molecular markers of active CSR. 34 We observed decreased levels of I␥2a, I␥2b, I␥3, and I␣ circular transcripts in Sap-deficient B cells stimulated with either LPS or anti-CD40 in combination with IL-4, IFN-␥ or TGF-␤1. This result indicates a defect in Ig class switch in Sap-deficient B cells, which is not Th1-or Th2-cytokine dependent. We further tested other components of Ig transcriptional machinery (eg, activation-induced cytidine deaminase [AID] and T-bet) in Sap-deficient mice. The AID gene is expressed in activated B cells and is essential to both CSR and somatic hypermutation (SHM). [42] [43] [44] The T-box transcription factor T-bet is involved in IgG class switch, especially IgG2a, by regulating germ-line transcription. 45, 46 Interestingly, no differences in AID and T-bet expression were observed between wild-type and Sap-deficient B cells (data not shown). Thus, another pathway or pathways, which remain to be determined, may be responsible for the impaired Ig class switch in B cells from Sap-deficient mice. In exploring the potential role for SAP in CSR, one must consider the finding of Sylla et al, who demonstrated that the wild-type form of the SAP protein has an affinity for Ku70 and Ku80 proteins, 47 which are known to be required for CSR. 48, 49 Therefore, one possibility is that SAP may be linked to some components of the CSR machinery.
Taken together, the impaired in vitro Ig production in Sapdeficient B cells and the decreased level of CSR suggest a B-cell dysfunction in Sap-deficient mice in addition to the abnormal CD4 ϩ T-cell help previously reported. [20] [21] [22] 27 Its presence in wildtype B cells further supports the concept that the adaptor molecule SAP directly regulates B-cell function. This significant finding may provide novel insights into the pathology and/or mechanism of the XLP disease.
